LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Accounts Payable, Current in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Lifecore Biomedical, Inc. \De\ quarterly Accounts Payable, Current history and growth rate from Q2 2011 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Accounts Payable, Current for the quarter ending August 25, 2024 was $18M, a 14.8% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $18M +$2.32M +14.8% Aug 25, 2024 10-Q 2024-10-04
Q2 2024 $16.3M -$5.76M -26.1% May 26, 2024 10-Q 2024-10-04
Q1 2024 $15.7M +$1.03M +7.01% Feb 25, 2024 10-Q 2024-08-09
Q4 2023 $19M +$5.72M +43% Nov 26, 2023 10-Q 2024-08-09
Q3 2023 $15.7M +$6.07M +63.1% Aug 27, 2023 10-Q 2024-08-09
Q2 2023 $22.1M +$9.15M +70.6% May 28, 2023 10-K 2024-08-26
Q1 2023 $14.7M +$1.36M +10.3% Feb 26, 2023 10-K 2024-03-20
Q4 2022 $13.3M +$4.65M +53.7% Nov 27, 2022 10-K 2024-03-20
Q3 2022 $9.62M +$1.02M +11.8% Aug 28, 2022 10-K 2024-03-20
Q2 2022 $13M +$1.33M +11.4% May 29, 2022 10-K 2024-03-20
Q1 2022 $13.3M +$4.41M +49.6% Feb 27, 2022 10-K 2024-03-20
Q4 2021 $8.66M +$670K +8.39% Nov 28, 2021 10-K 2024-03-20
Q3 2021 $8.61M +$2.26M +35.5% Aug 29, 2021 10-K 2024-03-20
Q2 2021 $11.6M -$40M -77.5% May 30, 2021 10-K 2024-03-20
Q1 2021 $8.89M -$54.8M -86% Feb 28, 2021 10-K 2024-03-20
Q4 2020 $7.99M -$39.2M -83.1% Nov 29, 2020 10-K 2024-03-20
Q3 2020 $6.35M -$39.8M -86.2% Aug 30, 2020 10-K 2024-03-20
Q2 2020 $51.6M -$2.33M -4.31% May 31, 2020 10-K 2021-07-29
Q1 2020 $63.7M +$17.2M +37.1% Feb 23, 2020 10-Q 2020-04-03
Q4 2019 $47.1M +$15.4M +48.6% Nov 24, 2019 10-Q 2020-01-02
Q3 2019 $46.2M +$19.1M +70.8% Aug 25, 2019 10-Q 2019-10-03
Q2 2019 $54M +$19.3M +55.7% May 26, 2019 10-K 2020-08-14
Q1 2019 $46.4M +$11.2M +31.8% Feb 24, 2019 10-Q 2019-04-04
Q4 2018 $31.7M -$5.76M -15.4% Nov 25, 2018 10-Q 2019-01-07
Q3 2018 $27M +$76K +0.28% Aug 26, 2018 10-Q 2018-10-05
Q2 2018 $34.7M +$10.1M +41.3% May 27, 2018 10-K 2019-08-01
Q1 2018 $35.2M +$10.5M +42.3% Feb 25, 2018 10-Q 2018-04-05
Q4 2017 $37.5M +$11.6M +44.6% Nov 26, 2017 10-Q 2018-01-05
Q3 2017 $27M -$4.66M -14.7% Aug 27, 2017 10-Q 2017-09-28
Q2 2017 $24.5M -$6.38M -20.6% May 28, 2017 10-K 2018-08-09
Q1 2017 $24.8M -$327K -1.3% Feb 26, 2017 10-Q 2017-04-07
Q4 2016 $25.9M -$11M -29.8% Nov 27, 2016 10-Q 2017-01-05
Q3 2016 $31.6M -$333K -1.04% Aug 28, 2016 10-Q 2016-09-29
Q2 2016 $30.9M -$4.11M -11.7% May 29, 2016 10-K/A 2018-03-15
Q1 2016 $25.1M -$3.08M -10.9% Feb 28, 2016 10-Q 2016-03-30
Q4 2015 $36.9M -$2.26M -5.78% Nov 29, 2015 10-Q 2016-01-07
Q3 2015 $31.9M -$5.27M -14.2% Aug 30, 2015 10-Q 2015-10-01
Q2 2015 $35M +$3.03M +9.47% May 31, 2015 10-K 2016-08-01
Q1 2015 $28.2M -$1.46M -4.93% Mar 1, 2015 10-Q 2015-04-02
Q4 2014 $39.2M +$4.67M +13.5% Nov 30, 2014 10-Q 2015-01-09
Q3 2014 $37.2M +$8.13M +28% Aug 31, 2014 10-Q 2014-10-08
Q2 2014 $32M -$50K -0.16% May 25, 2014 10-K 2015-07-31
Q1 2014 $29.6M +$1.89M +6.8% Feb 23, 2014 10-Q 2014-03-28
Q4 2013 $34.5M +$8.58M +33.1% Nov 24, 2013 10-Q 2014-01-03
Q3 2013 $29.1M +$2.36M +8.83% Aug 25, 2013 10-Q 2013-09-26
Q2 2013 $32M +$9.39M +41.5% May 26, 2013 10-K 2014-08-01
Q1 2013 $27.7M +$13.3M +91.9% Feb 24, 2013 10-Q 2013-04-04
Q4 2012 $25.9M +$7.06M +37.4% Nov 25, 2012 10-Q 2013-01-04
Q3 2012 $26.7M +$8.56M +47.2% Aug 26, 2012 10-Q/A 2013-01-02
Q2 2012 $22.6M +$5.9M +35.2% May 27, 2012 10-K 2013-08-07
Q1 2012 $14.5M Feb 26, 2012 10-Q 2012-03-28
Q4 2011 $18.9M Nov 27, 2011 10-Q 2012-01-05
Q3 2011 $18.2M Aug 28, 2011 10-Q 2011-10-05
Q2 2011 $16.7M May 29, 2011 10-K 2012-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.